Lista de obras - Gennaro Daniele - Dominio Público Uruguay

A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.

artículo científico publicado en 2014

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

artículo científico publicado en 2015

Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials

artículo científico publicado en 2011

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

artículo científico

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

artículo científico

Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.

artículo científico publicado en 2011

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

scientific article published on 12 March 2012

Cetuximab in non-small-cell lung cancer

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

artículo científico

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

artículo científico publicado en 2008

FGF receptor inhibitors: role in cancer therapy

artículo científico

Gefitinib in non small cell lung cancer

artículo científico publicado en 2011

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

artículo científico publicado en 2013

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

artículo científico publicado en 2013

New biological treatments for gynecological tumors: focus on angiogenesis

artículo científico

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

artículo científico publicado en 2010

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

artículo científico publicado en 2015

Pharmacokinetic evaluation of capecitabine in breast cancer

artículo científico

Pharmacokinetic evaluation of zoledronic acid.

artículo científico publicado en 2011

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

artículo científico publicado en 2014

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

artículo científico publicado en 2015

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

artículo científico publicado en 2012

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

artículo científico publicado en 2013

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

artículo científico publicado en 2015

Time spent for activation of non-profit studies in oncology in Italy

artículo científico publicado en 2010

Treatment of small cell lung cancer

scholarly article by Alessandro Morabito et al published September 2014 in Critical Reviews in Oncology Hematology

Vandetanib: An overview of its clinical development in NSCLC and other tumors.

artículo científico publicado en 2010

Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.

artículo científico publicado en 2008

Vinorelbine for non-small cell lung cancer.

artículo científico publicado en 2010

Lista de obras de Gennaro Daniele

A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

Cetuximab in non-small-cell lung cancer

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

FGF receptor inhibitors: role in cancer therapy

Gefitinib in non small cell lung cancer

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

New biological treatments for gynecological tumors: focus on angiogenesis

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

Pharmacokinetic evaluation of capecitabine in breast cancer

Pharmacokinetic evaluation of zoledronic acid.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Time spent for activation of non-profit studies in oncology in Italy

Treatment of small cell lung cancer

Vandetanib: An overview of its clinical development in NSCLC and other tumors.

Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.

Vinorelbine for non-small cell lung cancer.